We are live on ! Find out more
PFCS

Pale Fire Capital SE Portfolio holdings

AUM $1.14B
1-Year Est. Return 42.87%
This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
+42.87%
3 Year Est. Return
+176.09%
5 Year Est. Return
10 Year Est. Return
AUM
$887M
AUM Growth
+$169M
Cap. Flow
+$106M
Cap. Flow %
11.9%
Top 10 Hldgs %
92.79%
Holding
65
New
13
Increased
11
Reduced
11
Closed
18

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$182M
2
BTG icon
B2Gold
BTG
+$52.2M
3
DOLE icon
Dole
DOLE
+$6.44M
4
TDOC icon
Teladoc Health
TDOC
+$3.66M
5
WBD icon
Warner Bros
WBD
+$3.52M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$32.6M
2
SHEL icon
Shell
SHEL
+$30.7M
3
INSW icon
International Seaways
INSW
+$19M
4
STNG icon
Scorpio Tankers
STNG
+$18.8M
5
VOD icon
Vodafone
VOD
+$11.4M

Sector Composition

Rank Sector Weight
1 Communication Services 42.47%
2 Energy 30.92%
3 Consumer Staples 12.35%
4 Materials 8.1%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLYS icon
26
Mineralys Therapeutics
MLYS
$2.36B
$408K 0.05%
34,888
+5,973
+21% +$75.2K
QURE icon
27
uniQure
QURE
$2.82B
$294K 0.03%
65,600
MNKD icon
28
CALL
MannKind Corp
MNKD
$1.2B
$194K 0.02%
37,100
CELC icon
29
Celcuity
CELC
$4.1B
$191K 0.02%
11,653
+1,384
+13% +$23.2K
BDTX icon
30
Black Diamond Therapeutics
BDTX
$97.4M
$182K 0.02%
39,000
+5,303
+16% +$28.5K
INZY
31
DELISTED
Inozyme Pharma
INZY
$173K 0.02%
+38,901
New +$189K
CMRX
32
DELISTED
Chimerix, Inc.
CMRX
$146K 0.02%
166,207
+61,411
+59% +$58.2K
IMTX icon
33
Immatics
IMTX
$1.24B
$134K 0.02%
+11,524
New +$130K
TCRX icon
34
TScan Therapeutics
TCRX
$49.4M
$126K 0.01%
21,573
IOVA icon
35
Iovance Biotherapeutics
IOVA
$2.1B
$118K 0.01%
14,700
+3,700
+34% +$39.6K
RNW icon
36
ReNew
RNW
$2.21B
$110K 0.01%
17,621
-52,830
-75% -$317K
LRMR icon
37
Larimar Therapeutics
LRMR
$387M
$104K 0.01%
+14,292
New +$109K
XFOR icon
38
X4 Pharmaceuticals
XFOR
$381M
$103K 0.01%
5,901
+4,632
+365% +$151K
AVXL icon
39
CALL
Anavex Life Sciences
AVXL
$235M
$97.1K 0.01%
23,000
CMPX icon
40
Compass Therapeutics
CMPX
$360M
$82.8K 0.01%
82,777
-43,191
-34% -$63.1K
ODV
41
DELISTED
Osisko Development Corp
ODV
$65.2K 0.01%
+35,060
New +$74.2K
CRBU icon
42
Caribou Biosciences
CRBU
$148M
$64.1K 0.01%
39,107
+17,407
+80% +$55.6K
RVNC
43
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
$51.4K 0.01%
20,000
RAPT
44
DELISTED
RAPT Therapeutics
RAPT
$49K 0.01%
+2,009
New +$92.8K
LYG icon
45
Lloyds Banking Group
LYG
$86.2B
$36.9K ﹤0.01%
+13,510
New +$36.2K
ATAI icon
46
AtaiBeckley Inc
ATAI
$2.65B
$33K ﹤0.01%
+24,784
New +$44.7K
RVPH
47
CALL
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$32K ﹤0.01%
1,250
BABA icon
48
Alibaba
BABA
$280B
-450,000
Closed -$32.6M
CDTX
49
DELISTED
Cidara Therapeutics
CDTX
-3,327
Closed -$61.2K
CVE icon
50
Cenovus Energy
CVE
$54.1B
-100,000
Closed -$2M

Similar funds

Pale Fire Capital SE's Q2 2024 Portfolio in Review

As of Q2 2024, Pale Fire Capital SE held 65 positions worth $887M, up 24% from $718M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Pale Fire Capital SE deployed $106M of net new capital in Q2 2024, opening 13 new positions and adding to 11 existing holdings. Its largest new stake was AT&T: 10,482,716 shares worth $200M.

By sector, the portfolio is most concentrated in Communication Services at 42% of assets, up from 24% a quarter earlier, followed by Energy and Consumer Staples.

On the sell side, the largest reduction was Shell, an estimated $30.7M trimmed.

  • Pale Fire Capital SE's largest Q2 2024 buy was AT&T: 10,482,716 shares worth $200M.
  • Pale Fire Capital SE added most to Dole in Q2 2024, an estimated $6.44M increase.
  • Pale Fire Capital SE's biggest Q2 2024 reduction was Shell, cutting an estimated $30.7M.
  • Pale Fire Capital SE fully exited Alibaba in Q2 2024, selling an estimated $32.6M.
  • Pale Fire Capital SE's ten largest holdings make up 93% of its $887M portfolio in Q2 2024.
  • Pale Fire Capital SE opened 13 new positions and closed 18 in Q2 2024.
  • Pale Fire Capital SE's portfolio value rose 24% quarter-over-quarter to $887M.

Based on Pale Fire Capital SE's 13F filing for Q2 2024, filed 13 Aug 2024.